Arrowhead Pharmaceuticals's total assets for Q2 2025 were $1.57B, an increase of 55.22% from the previous quarter. ARWR total liabilities were $889.27M for the fiscal quarter, a -7.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.